A Switch Study of BMS-337039 in Schizophrenic Out-patients

Mise à jour : Il y a 4 ans
Référence : NCT00232687

Femme et Homme

Extrait

The purpose of this clinical research study is to evaluate the safety and tolerability of two switching strategies from risperidone to aripiprazole over a period of 12 weeks in out-patients who are treated in a general psychiatric practice setting and who are currently experiencing efficacy and/or safety/tolerability issues while on risperidone.


Critère d'inclusion

  • Schizophrenia


Liens